JPY 1074.0
(0.09%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.14 Billion JPY | 0.65% |
2022 | 3.12 Billion JPY | -6.97% |
2021 | 3.36 Billion JPY | 70.85% |
2020 | 1.96 Billion JPY | -3.59% |
2019 | 2.04 Billion JPY | -7.88% |
2018 | 2.21 Billion JPY | -13.51% |
2017 | 2.56 Billion JPY | 8.13% |
2016 | 2.36 Billion JPY | 0.69% |
2015 | 2.35 Billion JPY | -13.32% |
2014 | 2.71 Billion JPY | -10.46% |
2013 | 3.03 Billion JPY | 14.07% |
2012 | 2.65 Billion JPY | 8.26% |
2011 | 2.45 Billion JPY | 7.14% |
2010 | 2.29 Billion JPY | -9.44% |
2009 | 2.53 Billion JPY | -1.94% |
2008 | 2.58 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 3.23 Billion JPY | 2.7% |
2023 Q1 | 3.05 Billion JPY | -2.5% |
2023 Q3 | 3.51 Billion JPY | 16.67% |
2023 Q4 | 3.14 Billion JPY | -10.35% |
2023 Q2 | 3.01 Billion JPY | -1.3% |
2023 FY | 3.14 Billion JPY | 0.65% |
2022 Q2 | 3.04 Billion JPY | -6.07% |
2022 Q3 | 3.1 Billion JPY | 1.91% |
2022 FY | 3.12 Billion JPY | -6.97% |
2022 Q4 | 3.12 Billion JPY | 0.81% |
2022 Q1 | 3.24 Billion JPY | -3.59% |
2021 Q2 | 3 Billion JPY | -8.43% |
2021 FY | 3.36 Billion JPY | 70.85% |
2021 Q4 | 3.36 Billion JPY | 9.87% |
2021 Q1 | 3.28 Billion JPY | 66.92% |
2021 Q3 | 3.06 Billion JPY | 1.74% |
2020 FY | 1.96 Billion JPY | -3.59% |
2020 Q3 | 1.94 Billion JPY | 0.27% |
2020 Q2 | 1.94 Billion JPY | 1.48% |
2020 Q1 | 1.91 Billion JPY | -6.29% |
2020 Q4 | 1.96 Billion JPY | 1.11% |
2019 Q3 | 2.11 Billion JPY | -8.83% |
2019 Q4 | 2.04 Billion JPY | -3.41% |
2019 FY | 2.04 Billion JPY | -7.88% |
2019 Q1 | 2.19 Billion JPY | -0.95% |
2019 Q2 | 2.31 Billion JPY | 5.6% |
2018 Q2 | 2.35 Billion JPY | -8.92% |
2018 Q1 | 2.58 Billion JPY | 1.02% |
2018 Q4 | 2.21 Billion JPY | -10.49% |
2018 FY | 2.21 Billion JPY | -13.51% |
2018 Q3 | 2.47 Billion JPY | 5.02% |
2017 Q3 | 2.43 Billion JPY | 3.1% |
2017 FY | 2.56 Billion JPY | 8.13% |
2017 Q2 | 2.36 Billion JPY | -3.09% |
2017 Q1 | 2.43 Billion JPY | 2.78% |
2017 Q4 | 2.56 Billion JPY | 5.31% |
2016 Q3 | 2.28 Billion JPY | 1.37% |
2016 Q1 | 2.41 Billion JPY | 2.75% |
2016 Q2 | 2.25 Billion JPY | -6.72% |
2016 Q4 | 2.36 Billion JPY | 3.65% |
2016 FY | 2.36 Billion JPY | 0.69% |
2015 FY | 2.35 Billion JPY | -13.32% |
2015 Q1 | 2.47 Billion JPY | -8.7% |
2015 Q4 | 2.35 Billion JPY | -0.83% |
2015 Q3 | 2.37 Billion JPY | 10.1% |
2015 Q2 | 2.15 Billion JPY | -13.04% |
2014 FY | 2.71 Billion JPY | -10.46% |
2014 Q4 | 2.71 Billion JPY | 1.95% |
2014 Q3 | 2.66 Billion JPY | 6.98% |
2014 Q2 | 2.48 Billion JPY | -3.91% |
2014 Q1 | 2.59 Billion JPY | -14.56% |
2013 Q2 | 2.65 Billion JPY | -0.11% |
2013 Q3 | 2.65 Billion JPY | -0.34% |
2013 Q4 | 3.03 Billion JPY | 14.4% |
2013 Q1 | 2.66 Billion JPY | 0.17% |
2013 FY | 3.03 Billion JPY | 14.07% |
2012 Q4 | 2.65 Billion JPY | 11.36% |
2012 Q2 | 2.51 Billion JPY | -3.9% |
2012 Q3 | 2.38 Billion JPY | -5.22% |
2012 FY | 2.65 Billion JPY | 8.26% |
2012 Q1 | 2.62 Billion JPY | 6.73% |
2011 Q3 | 2.22 Billion JPY | 8.59% |
2011 Q2 | 2.04 Billion JPY | -6.89% |
2011 Q1 | 2.19 Billion JPY | -4.0% |
2011 Q4 | 2.45 Billion JPY | 10.38% |
2011 FY | 2.45 Billion JPY | 7.14% |
2010 Q4 | 2.29 Billion JPY | 0.76% |
2010 Q3 | 2.27 Billion JPY | -5.51% |
2010 FY | 2.29 Billion JPY | -9.44% |
2010 Q2 | 2.4 Billion JPY | -3.27% |
2010 Q1 | 2.48 Billion JPY | -1.67% |
2009 Q2 | 2.56 Billion JPY | 0.0% |
2009 Q3 | 2.33 Billion JPY | -9.05% |
2009 Q4 | 2.53 Billion JPY | 8.36% |
2009 FY | 2.53 Billion JPY | -1.94% |
2008 FY | 2.58 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -90.526% |
Euglena Co., Ltd. | 37.92 Billion JPY | 91.697% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | 51.5% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 78.404% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 85.263% |
Kao Corporation | 757.7 Billion JPY | 99.584% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 66.346% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 96.824% |
Shiseido Company, Limited | 615.1 Billion JPY | 99.488% |
Lion Corporation | 188.22 Billion JPY | 98.327% |
Mandom Corporation | 20.05 Billion JPY | 84.3% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -137.327% |
Milbon Co., Ltd. | 7.45 Billion JPY | 57.788% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 76.779% |
Fancl Corporation | 30.56 Billion JPY | 89.699% |
KOSÉ Corporation | 88.61 Billion JPY | 96.447% |
Cota Co., Ltd. | 3.85 Billion JPY | 18.268% |
HABA Laboratories,Inc. | 3.92 Billion JPY | 19.756% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 90.533% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 86.902% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -195.919% |
Almado, Inc. | 1.94 Billion JPY | -61.78% |
I-ne CO., LTD. | 8.57 Billion JPY | 63.292% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 35.474% |
Liberta Co.,Ltd. | 3.88 Billion JPY | 18.919% |
AXXZIA Inc. | 2 Billion JPY | -56.936% |
S.T. Corporation | 12.01 Billion JPY | 73.784% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 94.974% |
Earth Corporation | 60.4 Billion JPY | 94.787% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 59.621% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -95.211% |
Ya-Man Ltd. | 3.97 Billion JPY | 20.812% |
MTG Co., Ltd. | 11.73 Billion JPY | 73.176% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | 24.526% |
SHOBIDO Corporation | 8.89 Billion JPY | 64.609% |
Artnature Inc. | 23.42 Billion JPY | 86.559% |
Pigeon Corporation | 19.34 Billion JPY | 83.726% |
Unicharm Corporation | 345.37 Billion JPY | 99.088% |
Paltac Corporation | 222.34 Billion JPY | 98.584% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 88.957% |